Avansci Bio is a U startup that has developed the MESO-1 Dissection Workstation, a novel technology that automates dissection from slide mounted tissue, improving accuracy, consistency, efficiency and provides a significant technical advancement for both clinical/research pathology and histology laboratories. Their products are derived from the research of Drs. Katherine Geiersbach, assistant professor of pathology at the U and Nils Adey, formerly of BioMicro Systems. In December, 2014 Roche Diagnostics signed a definitive Asset Purchase Agreement with AvanSci Bio for all products associated with their dissection technologies.
Location: United States, Utah, Salt Lake City
Member count: 1-10
Founded date: 2011
Investors 1
| Date | Name | Website |
| - | Technology... | pivotcente... |